According to a 1997 report by the Washington Post, the abortion pill was initially projected to reach $100 million in sales every year. It’s no wonder, then, that those involved in the pill’s early approval planned for the abortion pill manufacturer to eventually transition from a non-profit to for-profit company. And where there is big profit, there is often secrecy. The abortion pill is no exception; even today the pill’s manufacturing location and many of its funders are still cloaked in secrecy.
In 2000, the New York Daily News wrote:
“The pill’s 11-year journey to the United States included a cloak-and-dagger scheme to hide the identities of participants…allegations of fraud, a dozen lawsuits, and a price tag of at least $50 million….
Citing fear… Danco refuses to release the names of its executives and investors. The company even persuaded the Food and Drug Administration to keep secret the location of the factory where the abortion drug will be produced….
In a strange twist, the FDA acceded to Danco’s request that the name of its manufacturer be kept secret — and even shielded the names of the FDA researchers who had overseen the pill’s approval.”
Read more at LiveAction News >>